Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease
Abstract: Introduction: There is a close relationship between the relapse of inflammatory bowel disease (IBD) and lifestyle factors, including concomitant medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), antithrombotic drugs, smoking status, and alcohol consumption. However, solid evidence is limited regarding the risk factors at diagnosis and initial disease course. This study aimed to explore the impact of concomitant prescriptions and lifestyle factors in patients with newly diagnosed IBD using a large-scale real-world database. Methods: This is a retrospective inception cohort study using the insurance claims database. Newly diagnosed patients with UC and CD were enrolled between January 2005 and May 2020. Concomitant prescriptions and lifestyle factors were assessed for new biologics use, surgery, and hospitalization during the first year. Results: In total, 6,743 patients with UC and 1,000 patients with CD were enrolled. Proton pump inhibitors, antithrombotics, antibiotics, and NSAIDs were identified as associated factors for both biologics use and hospitalization in UC patients (all p < 0.01), and antithrombotics were identified as associated factors for both biologics use and hospitalization in CD patients (all p < 0.01) in multivariable analyses. Interestingly, smoking was protective against hospitalization in UC patients (p < 0.01) but not in CD patients (p = 0.997), analyzed by univariate analysis. Alcohol consumption was protective against hospitalization outcomes in UC patients (p = 0.02) but not in CD patients (p = 0.27), analyzed by univariate analysis. Conclusion: Immediate attention should be paid to concomitant medications at diagnosis because they may have impact on the initial course of IBD.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease ; volume:9 ; number:1 ; year:2024 ; pages:260-270 ; extent:11
Inflammatory intestinal diseases ; 9, Heft 1 (2024), 260-270 (gesamt 11)
- Urheber
-
Morikubo, Hiromu
Nagahama, Takayoshi
Nagai, Katsuhiko
Yamazaki, Hajime
Kobayashi, Taku
- DOI
-
10.1159/000541984
- URN
-
urn:nbn:de:101:1-2412260120520.047297849101
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Morikubo, Hiromu
- Nagahama, Takayoshi
- Nagai, Katsuhiko
- Yamazaki, Hajime
- Kobayashi, Taku
Ähnliche Objekte (12)
Medical visits, antihypertensive prescriptions and medication adherence among newly diagnosed hypertensive patients in Korea
Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children
Concomitant sexually transmitted diseases in patients with newly diagnosed HIV in Sri Lanka
Frequency, prognosis and treatment modalities of newly diagnosed small bowel cancer with liver metastases
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
B-cell lymphoma with bowel-to-bowel penetration diagnosed by double-balloon endoscopy
De prescriptions.
Medical visits, antihypertensive prescriptions and medication adherence among newly diagnosed hypertensive patients in Korea
Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children
Concomitant sexually transmitted diseases in patients with newly diagnosed HIV in Sri Lanka
Frequency, prognosis and treatment modalities of newly diagnosed small bowel cancer with liver metastases
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
B-cell lymphoma with bowel-to-bowel penetration diagnosed by double-balloon endoscopy
De prescriptions.
Medical visits, antihypertensive prescriptions and medication adherence among newly diagnosed hypertensive patients in Korea
Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children
Concomitant sexually transmitted diseases in patients with newly diagnosed HIV in Sri Lanka
Frequency, prognosis and treatment modalities of newly diagnosed small bowel cancer with liver metastases
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
B-cell lymphoma with bowel-to-bowel penetration diagnosed by double-balloon endoscopy